Tuberculosis

Learn how Mabtech solutions have been used in TB research by scientists worldwide below. From human diagnostics and vaccine research to rhino conservation efforts, read how ELISpot, FluoroSpot, and ELISA can answer your specific TB research questions.

Behind the scenes, Published November 17, 2023

Webinar: Novel insights into TB vaccines and diagnostics
Recording now available!

Highlighted research, Published May 16, 2019

TB screening in rhinos using our equine(!) ELISA kit
Mabtech’s equine IFN-γ ELISA showed the highest sensitivity for measuring endogenous IFN-γ in rhinoceros.

Featured product, Published September 2, 2021

Our TB peptide pools go Path
Our PepPools for tuberculosis were combined into ELISpot and FluoroSpot Path kits.

Highlighted research, Published September 14, 2023

TB antigens in active vs latent infection
Cecilia Lindestam Arlehamn and co-workers have developed a novel peptide pool that distinguishes active tuberculosis from latent infection.

Highlighted research, Published December 21, 2023

White paper: Tuberculosis diagnosis with spots
Early and precise diagnosis is crucial for effective TB management, and ELISpot is increasingly being used for this purpose. This white paper examines the advantages of ELISpot in TB diagnosis and suggests future antigens and biomarkers that can enhance diagnostic accuracy.